Skip to main content

Michael Kelliher

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Kelliher

Michael Kelliher is recorded as Board Member at Capricor Therapeutics, Inc. (CAPR). Capricor Therapeutics, Inc. reported in an 8-K filed May 27, 2025 that Michael Kelliher was appointed director, effective May 22, 2025. Capricor Therapeutics, Inc. reported in an 8-K filed September 6, 2023 that Michael Kelliher was appointed member of the Board, effective September 1, 2023.

“Each of Frank Litvack, M.D., Linda Marbán, Ph.D., David B. Musket, George W. Dunbar, Jr., Karimah Es Sabar, Paul Auwaerter, M.D., Philip Gotwals, Ph.D., and Michael Kelliher were elected as directors of the Company to serve until the 2026 annual meeting of stockholders, and until his or her successor is elected, or until his or her earlier death, resignation or removal, as follows:”
Capricor Therapeutics, Inc. Form 8-K, filed May 27, 2025 · Read the filing
“On September 1, 2023, the Board of Directors (the "Board") of Capricor Therapeutics, Inc. (the "Company"), pursuant to the authority given to it under the Certificate of Incorporation and Bylaws of the Company, approved an increase of the size of the Board from eight to nine directors, and thereafter elected Michael Kelliher as a member of the Board to fill the newly created vacancy, effective immediately.”
Capricor Therapeutics, Inc. Form 8-K, filed September 6, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Capricor Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.